Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study.

Autor: Hutton, J. Thomas, Metman, Leo Verhagen, Chase, Thomas N., Juncos, Jorge L., Koller, William C., Pahwa, Rajesh, LeWitt, Peter A., Samii, Ali, Tsui, Joseph K.C., Calne, Donald B., Waters, Cheryl H., Calabrese, Vincent P., Bennett, James P., Barrett, Richard, Morris, Jerry L.
Zdroj: Movement Disorders; May2001, Vol. 16 Issue 3, p459-463, 5p
Databáze: Complementary Index